Nitazoxanide Is an Ineffective Treatment of Chronic Norovirus in Patients With X-Linked Agammaglobulinemia and May Yield False-Negative Polymerase Chain Reaction Findings in Stool Specimens

Abstract excerpt

Tothe Editor—Thorne et al have recently reviewed antiviral therapeutic approaches for norovirus infection [1]. The authors concluded that nitazoxanide was the only compound to have undergone preliminary trial testing as a potential antiviral therapy for norovirus, having previously been shown to reduce symptom duration in immunocompetent patients, as well as to resolve symptoms in a single chronically infected...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Cytomegalovirus and herpesvirus research
• Share to Immunodeficiency and Autoimmune Disorders